Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» earnings
earnings
Q3 recap: Medtech firms grapple with layoffs, GLP-1s and China slowdown
Q3 recap: Medtech firms grapple with layoffs, GLP-1s and China slowdown
Medtech Dive
Medtech
earnings
inflation
China
layoffs
Flag link:
Half a year later, Teva's 'pivot to growth' strategy appears to be bearing fruit
Half a year later, Teva's 'pivot to growth' strategy appears to be bearing fruit
Fierce Pharma
Teva Pharmaceutical
earnings
Flag link:
Illumina cuts annual profit forecast for second straight quarter
Illumina cuts annual profit forecast for second straight quarter
Yahoo/Reuters
Illumina
earnings
Medtech
diagnostics
Flag link:
AstraZeneca pays $185M upfront to reenter oral obesity gold rush, drops phase 2 sickle cell drug
AstraZeneca pays $185M upfront to reenter oral obesity gold rush, drops phase 2 sickle cell drug
Fierce Biotech
AstraZeneca
obesity
sickle cell disease
Eccogene
earnings
Flag link:
Novavax posts higher-than-expected revenue, says prepared to further cut costs
Novavax posts higher-than-expected revenue, says prepared to further cut costs
Reuters
Novavax
earnings
vaccines
COVID-19
Flag link:
Teva Pharma Makes A Bullish Move After Quarterly Beat, Business Separation Plans
Teva Pharma Makes A Bullish Move After Quarterly Beat, Business Separation Plans
Investors Business Daily
Teva Pharmaceutical
earnings
Flag link:
As Biogen's sales flatline, CEO Chris Viehbacher touts progress on Leqembi, Skyclarys and other launches
As Biogen's sales flatline, CEO Chris Viehbacher touts progress on Leqembi, Skyclarys and other launches
Fierce Pharma
Biogen
Pharma CEOs
Chris Viehbacher
earnings
Leqembi
Skyclarys
Flag link:
Gilead Tumbles After An Unpredictable Element Drove Its Third-Quarter Beat
Gilead Tumbles After An Unpredictable Element Drove Its Third-Quarter Beat
Investors Business Daily
Gilead Sciences
earnings
Veklury
Flag link:
Biogen's M&A, Alzheimer's drug launch costs spark profit forecast cut
Biogen's M&A, Alzheimer's drug launch costs spark profit forecast cut
Reuters
Biogen
Alzheimer's disease
Leqembi
Reata
M&A
earnings
Flag link:
Axsome expands sales force to support launch of fast-growing depression med Auvelity
Axsome expands sales force to support launch of fast-growing depression med Auvelity
Fierce Pharma
Axesome Therapeutics
Auvelity
hirings
earnings
Flag link:
BioNTech Stock Jumps On Surprise Profit, Sales Beat
BioNTech Stock Jumps On Surprise Profit, Sales Beat
Investors Business Daily
BioNTech
earnings
COVID-19
Flag link:
There's a Silver Lining in Pfizer's Dark Cloud
There's a Silver Lining in Pfizer's Dark Cloud
Motley Fool
Pfizer
earnings
Eliquis
Ibrance
patents
Flag link:
Lilly's blockbuster Mounjaro boosts third quarter results, supply issues persist
Lilly's blockbuster Mounjaro boosts third quarter results, supply issues persist
Reuters
Eli Lilly
earnings
Mounjaro
Flag link:
Moderna takes hefty $1.3B COVID write-off, scales back manufacturing as sales shrink
Moderna takes hefty $1.3B COVID write-off, scales back manufacturing as sales shrink
Fierce Pharma
Moderna Therapeutics
earnings
vaccines
COVID-19
Flag link:
Novo Nordisk shrugs off supply issues with record sales
Novo Nordisk shrugs off supply issues with record sales
Pharmaphorum
Novo Nordisk
Ozempic
earnings
Flag link:
Regeneron beats quarterly profit estimates on eczema treatment strength
Regeneron beats quarterly profit estimates on eczema treatment strength
Reuters
Regeneron
earnings
Dupixent
Flag link:
GSK Touts Strong Q3 Performance on the Back of Arexvy, Shingrix Sales
GSK Touts Strong Q3 Performance on the Back of Arexvy, Shingrix Sales
BioSpace
GSK
earnings
Arexvy
Shingrix
Flag link:
A continuing decline in sales of COVID-19 products clips revenue at Pfizer
A continuing decline in sales of COVID-19 products clips revenue at Pfizer
Yahoo Finance
Pfizer
earnings
COVID-19
vaccines
Paxlovid
Flag link:
Amgen stops trial of Teneobio cancer candidate, taking $650M BiTE out of earnings
Amgen stops trial of Teneobio cancer candidate, taking $650M BiTE out of earnings
Fierce Biotech
Amgen
earnings
Teneobio
bispecifics
Flag link:
4 medtech companies to watch this week in earnings
4 medtech companies to watch this week in earnings
Medtech Dive
Medtech
earnings
GE Healthcare
Stryker
ZimVie
Insulet
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »